Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Lexaria Bioscience Corp (LEXX)

Lexaria Bioscience Corp (LEXX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,301
  • Shares Outstanding, K 5,104
  • Annual Sales, $ 380 K
  • Annual Income, $ -4,080 K
  • 60-Month Beta 2.60
  • Price/Sales 30.87
  • Price/Cash Flow N/A
  • Price/Book 3.13
Trade LEXX with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.66 +18.73%
on 08/23/21
7.20 -6.67%
on 09/07/21
+0.91 (+15.66%)
since 08/20/21
3-Month
5.29 +27.03%
on 08/18/21
12.50 -46.24%
on 07/21/21
+0.10 (+1.51%)
since 06/22/21

Most Recent Stories

More News
Lexston Life Sciences Corp. Acquires Zenalytic Laboratories Ltd.

(via TheNewswire)

LEXX : 6.72 (+1.51%)
LEXXW : 2.49 (+1.63%)
LEXT.CN : 0.240 (-7.69%)
AVNT.TO : 0.52 (-1.89%)
AVTBF : 0.3950 (-4.70%)
CannabisNewsBreaks Lexaria Bioscience Corp.'s (NASDAQ: LEXX) DehydraTECH(TM) Enables Rapid, Sustained Drop in Blood Pressure

(MENAFN - Investor Brand Network) Lexaria Bioscience Corp. (NASDAQ: LEXX) , a global innovator of proprietary patented drug-delivery platform DehydraTECH(TM), recently released partial results from human...

LEXX : 6.72 (+1.51%)
Lexaria Bioscience Corp. (NASDAQ: LEXX) Draws Closer to NDA Filing for DehydraTECH CBD

(MENAFN - Investor Brand Network)

LEXX : 6.72 (+1.51%)
NetworkNewsAudio Lexaria Bioscience Corp. (NASDAQ: LEXX) Leading Out in Innovation of Hypertension Treatment

(MENAFN - Investor Brand Network) Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in the United States, or 108 million people, have hypertension, yet only about...

LEXX : 6.72 (+1.51%)
PFE : 43.95 (+0.07%)
MRK : 72.04 (+0.10%)
AZN : 58.74 (-0.66%)
MRNA : 440.72 (+1.54%)
Lexaria Bioscience Corp. (NASDAQ: LEXX) Emerging as Leader in Pursuit of More-Effective Hypertension Treatment

NetworkNewsAudio - Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, "Hypertension: The Silent Killer Making Loud Noise for Investors."

LXRP : 0.2249 (-10.68%)
LEXX : 6.72 (+1.51%)
Lexaria Bioscience Corp. (NASDAQ: LEXX) Making Great Strides Toward Filing IND Application for Patented DehydraTECH(TM) Technology

(MENAFN - Investor Brand Network)

LEXX : 6.72 (+1.51%)
Lexaria Bioscience Corp.'s (NASDAQ: LEXX) Throw Hat into Hypertension Ring with Proprietary Drug-Delivery System

via InvestorWire -- Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork...

LXRP : 0.2249 (-10.68%)
LEXX : 6.72 (+1.51%)
Lexaria Takes Another Step Towards NDA Filing for DehydraTECH- CBD

New York, New York--(Newsfile Corp. - September 14, 2021) - PCG Digital -- The most recent results from HYPER-H21-2, a human clinical study of the effects of Lexaria's DehydraTECH-processed CBD on blood...

LEXX : 6.72 (+1.51%)
Hypertension: The Silent Killer Making Loud Noise for Investors

/PRNewswire/ -- Hypertension, or high blood pressure, is rampant in America. An estimated 45% of adults in , or 108 million people, have hypertension, yet only about one out of every four have their condition...

LEXX : 6.72 (+1.51%)
PFE : 43.95 (+0.07%)
MRK : 72.04 (+0.10%)
AZN : 58.74 (-0.66%)
MRNA : 440.72 (+1.54%)
Lexaria Bioscience Corp. (NASDAQ: LEXX) Impressive Blood Pressure Reduction in Hypertension Clinical Trials

(MENAFN - Investor Brand Network)

LEXX : 6.72 (+1.51%)

Business Summary

Lexaria Bioscience Corp. provides drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules....

See More

Key Turning Points

3rd Resistance Point 7.03
2nd Resistance Point 6.90
1st Resistance Point 6.81
Last Price 6.72
1st Support Level 6.59
2nd Support Level 6.46
3rd Support Level 6.37

See More

52-Week High 12.50
Fibonacci 61.8% 9.24
Fibonacci 50% 8.24
Fibonacci 38.2% 7.23
Last Price 6.72
52-Week Low 3.98

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar